(Q34614339)

3 August 2017

1 reference

title

A new reality: achieving cholesterol-lowering goals in clinical practice (English)

1 reference

3 August 2017

Allan Gaw

1

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Atherosclerosis. Supplements

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

5-8; discussion 8-11

1 reference

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900018-6

7 January 2021

10.1016/S1567-5688(01)00018-6

Identifiers

DOI

1 reference

3 August 2017

1 reference